Salp15, biologically functional equivalents and fragments thereof, and
nucleic acid molecules encoding the same are disclosed. Recombinant host
cells, recombinant nucleic acids and recombinant proteins are also
disclosed. Salp15 gene products and Salp15 polypeptide fragments have
biological activity in modulating CD4+ T cell activation through specific
binding to CD4. Thus, therapeutic methods involving modulating T cell
activation using Salp15 and biologically active polypeptide fragments
thereof are also disclosed. The specific binding of Salp15 and fragment
peptides thereof to CD4 can inhibit HIV infection of T cells, and thus
methods of using Salp15 for inhibiting HIV infection are also disclosed.
Screening methods for selecting substances having an ability to modulate
activation of T cells are also disclosed.